[go: up one dir, main page]

AU2001262992A1 - System and method for intranasal administration of opioids - Google Patents

System and method for intranasal administration of opioids

Info

Publication number
AU2001262992A1
AU2001262992A1 AU2001262992A AU6299201A AU2001262992A1 AU 2001262992 A1 AU2001262992 A1 AU 2001262992A1 AU 2001262992 A AU2001262992 A AU 2001262992A AU 6299201 A AU6299201 A AU 6299201A AU 2001262992 A1 AU2001262992 A1 AU 2001262992A1
Authority
AU
Australia
Prior art keywords
opioids
intranasal administration
intranasal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262992A
Inventor
Daniel P. Wermeling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of AU2001262992A1 publication Critical patent/AU2001262992A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001262992A 2000-05-10 2001-05-04 System and method for intranasal administration of opioids Abandoned AU2001262992A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56912500A 2000-05-10 2000-05-10
US09569125 2000-05-10
PCT/US2001/014695 WO2002011778A1 (en) 2000-05-10 2001-05-04 System and method for intranasal administration of opioids

Publications (1)

Publication Number Publication Date
AU2001262992A1 true AU2001262992A1 (en) 2002-02-18

Family

ID=24274188

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262992A Abandoned AU2001262992A1 (en) 2000-05-10 2001-05-04 System and method for intranasal administration of opioids

Country Status (3)

Country Link
US (1) US20030077300A1 (en)
AU (1) AU2001262992A1 (en)
WO (1) WO2002011778A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
KR100888275B1 (en) * 2000-07-31 2009-03-10 니코메드 댄마크 에이에스 Fentanyl composition for nasal administration
US6948492B2 (en) 2000-08-15 2005-09-27 University Of Kentucky Research Foundation Programmable multi-dose intranasal drug delivery device
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
CN1674903A (en) * 2002-07-11 2005-09-28 大鹏药品工业株式会社 Composition for transnasal absorption
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
MXPA05009602A (en) * 2003-03-11 2005-11-08 Arakis Ltd Novel compositions containing fentanyl.
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
US20070093420A1 (en) 2005-08-26 2007-04-26 Yeomans David C Therapy procedure for drug delivery for trigeminal pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
RU2312662C1 (en) * 2006-05-10 2007-12-20 Открытое акционерное общество "Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко Butorphanol-base injection solution possessing analgesic effect
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
US9239906B2 (en) 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9649469B2 (en) * 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US9064036B2 (en) 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
WO2010005400A1 (en) * 2008-07-11 2010-01-14 Ix Biopharma Pte Ltd Opioid agonist compositions for pain management
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US8548623B2 (en) 2009-03-18 2013-10-01 Acelrx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
ES2632431T3 (en) 2009-10-30 2017-09-13 Ntf Therapeutics, Inc. Enhanced Neurturin Molecules
IT1400067B1 (en) * 2010-05-21 2013-05-17 Molteni & C LIQUID NASAL SPRAY CONTAINING NALTREXONE WITH LOW DOSAGE.
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
AT16553U1 (en) 2011-05-13 2020-01-15 Euro Celtique Sa Intranasal pharmaceutical forms comprising naloxone
CA2875384A1 (en) 2013-12-20 2015-06-20 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
HK1231370A1 (en) 2014-03-14 2017-12-22 欧皮安特制药有限公司 Nasal drug products and methods of their use
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
WO2016007729A1 (en) * 2014-07-09 2016-01-14 Lightlake Therapeutics Inc. Co-packaged drug products
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
BR112017013311B1 (en) 2014-12-23 2022-05-31 Acelrx Pharmaceuticals, Inc Device for dispensing oral and transmucosal dosage forms
HRP20231438T1 (en) 2015-01-07 2024-06-07 Tonix Pharma Limited Magnesium-containing oxytocin formulations and methods of use
FR3032353B1 (en) 2015-02-06 2017-03-10 Jacques Seguin PHARMACEUTICAL COMPOSITION AND DEVICE FOR THE TREATMENT OF PAIN
JP7093559B2 (en) 2016-04-12 2022-06-30 トライジェミナ， インコーポレイテッド Magnesium-containing oxytocin preparation and method of use
US10512592B1 (en) * 2017-10-13 2019-12-24 Amanpreet Sandhu Medication dispenser
US11862303B1 (en) 2018-04-19 2024-01-02 Telemedicine Health, Inc. Collection of digital health hubs with artificial intelligence
US11311460B1 (en) 2018-08-08 2022-04-26 Telemedicine Health, Inc. Method and apparatus of secure storage for dispensing of opioids (SSDO)
US11854680B1 (en) 2018-08-08 2023-12-26 Telemedicine Health, Inc. Narcotics and opioids secure storage and dispensing apparatus and method of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4973596A (en) * 1988-05-20 1990-11-27 Barr Laboratories, Inc. Method of administering a narcotic analgesic and dosage forms therefor
US5543434A (en) * 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain
US5855907A (en) * 1997-03-24 1999-01-05 Peyman; Gholam A. Method of treatment of migraine

Also Published As

Publication number Publication date
US20030077300A1 (en) 2003-04-24
WO2002011778A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2001262992A1 (en) System and method for intranasal administration of opioids
AU2001288372A1 (en) System and method for tele-ophthalmology
AU2002214667A1 (en) System and method for rapid telepositioning
AU2002243209A1 (en) Method and system for remote gaming
AU2001269373A1 (en) System and method for auto-bias of an amplifier
AU2002215326A1 (en) Low-powered communication system and method of operation
AU2001253877A1 (en) System and method for providing content interruptions
AU2001268061A1 (en) System and method for secure delivery of rich media
AU2001252949A1 (en) Electrical smoking system and method
AU2001257572A1 (en) Method and system for account activation
AU2001275737A1 (en) System and method of detecting events
AU2001283236A1 (en) System and method for remote roulette
AU2001247758A1 (en) System and method for picture-in-browser scaling
AU2001279315A1 (en) 3-d hlcd system and method of making
AU2002213227A1 (en) Generalizer system and method
AU2002230474A1 (en) Integrated method and system for communication
AU2002237711A1 (en) System and method for the delivery of information
AU2001295039A1 (en) System and method for mixture optimization
AU2001241480A1 (en) Method and system for synchronizing content
AU2002211526A1 (en) Method and system for detection of synchronization in communication systems
AU2001225600A1 (en) Insulation system, insulation method and use of insulation system
AU2001249305A1 (en) Method and system for identification of subterranean objects
AU2001236308A1 (en) Method and system for providing synchronization
AU2001275263A1 (en) System and method for terminal short detection
AU2002234144A1 (en) Copy-protection system and method